RxSight, Inc. (RXST)
6.35
+0.19
(+3.08%)
USD |
NASDAQ |
May 21, 16:00
6.345
0.00 (0.00%)
After-Hours: 19:59
RxSight Research and Development Expense (TTM) : 37.65M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alphatec Holdings, Inc. | 76.80M |
| Teleflex, Inc. | 188.87M |
| Abbott Laboratories | 2.954B |
| AngioDynamics, Inc. | 27.86M |
| Accuray, Inc. | 41.57M |